Doctors at Maastricht University in the Netherlands and other university research institutions randomly placed obese men on 150mg Trans-Resveratrol or placebo daily for 30 days. They then had a 30 day washout period without supplementation or placebo to remove the immediate effects of the supplement and were switched to the other group; those previously supplemented with Resveratrol were now on placebo and those previously on placebo now took Resveratrol for an additional 30 days. Giving the obese men Resveratrol improved metabolism and reduced blood sugar and insulin levels, reduced fat storage in the liver, improved energy production by enhancing mitochondrial function, and reduced markers of inflammation in the blood.

194 men with newly diagnosed prostate cancer were compared to 317 cancer-free men. Consuming lots of fat in the diet was connected to a 79% increased risk of developing prostate cancer. Frequent red meat consumption increased the risk by 69%.

The VITAL study included 66,227 men and women between the ages of 50 to 76 recruited between the years 2000 to 2002 who were then followed and hematological cancers were diagnosed through December 2008. VITAL stands for VITamins And Lifestyle cohort study. Hematological cancers include leukemia, lymphomas and bone cancers.

CRP is a protein in the blood that rises with inflammation. Ninety patients with elevated CRP were included in this study. The patients suffered with either osteoarthritis and/or rheumatoid arthritis and some additionally were diagnosed with cardiovascular disease.